| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bf7982dfa425ed0c2ca6362b1ce3f30 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2820-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10143 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 |
| filingDate |
2001-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d3ea3bff70aa6cfe90bc1e2aa2000e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01d9dc5ef4d465b88157c66f8470460e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82256928e570c613026a5c183db1c06a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af6d32d3661174bf130f8fcddf75141b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_462096dba030052eca0ea7faa54deb79 |
| publicationDate |
2001-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1149917-A2 |
| titleOfInvention |
Hepatitis B virus vectors for gene therapy |
| abstract |
The present invention relates to novel hepatitis B virus vectors for use in gene therapynwhich can deliver therapeutic genes to liver cells. The invention also provides methodsnfor the production of novel recombinant hepatitis B viruses. The recombinant virusesnproduced by this invention can deliver therapeutic genes specifically to liver cells eithernthrough in vivo or ex vivo therapy protocols. This vector can be used not only to treatnliver diseases but also genetic diseases. |
| priorityDate |
2000-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |